{"id":"https://openalex.org/W4404976104","doi":"https://doi.org/10.1158/1535-7163.c.7567731","title":"Data from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity","display_name":"Data from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity","publication_year":2024,"publication_date":"2024-12-03","ids":{"openalex":"https://openalex.org/W4404976104","doi":"https://doi.org/10.1158/1535-7163.c.7567731"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.7567731","doi":"https://doi.org/10.1158/1535-7163.c.7567731","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.7567731","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.7567731","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083063156","display_name":"Priyanka Shailendra Rana","orcid":"https://orcid.org/0000-0001-5774-4383","observed_orcids":["https://orcid.org/0000-0001-5774-4383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priyanka S. Rana","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5774-4383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012867231","display_name":"James John Ignatz-Hoover","orcid":"https://orcid.org/0000-0001-8196-2655","observed_orcids":["https://orcid.org/0000-0001-8196-2655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Ignatz-Hoover","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8196-2655","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065393544","display_name":"Chunna Guo","orcid":"https://orcid.org/0000-0001-6075-7441","observed_orcids":["https://orcid.org/0000-0001-6075-7441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunna Guo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6075-7441","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059619254","display_name":"Amber L. Mosley","orcid":"https://orcid.org/0000-0001-5822-2894","observed_orcids":["https://orcid.org/0000-0001-5822-2894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amber L. Mosley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5822-2894","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083283435","display_name":"Ehsan Malek","orcid":"https://orcid.org/0000-0003-4719-4327","observed_orcids":["https://orcid.org/0000-0003-4719-4327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ehsan Malek","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4719-4327","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109734528","display_name":"Yuriy Federov","orcid":"https://orcid.org/0000-0001-9513-8341","observed_orcids":["https://orcid.org/0000-0001-9513-8341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuriy Federov","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9513-8341","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025223840","display_name":"Drew Adams","orcid":"https://orcid.org/0000-0002-3038-336X","observed_orcids":["https://orcid.org/0000-0002-3038-336X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Drew J. Adams","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3038-336X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035898667","display_name":"James Joseph Driscoll","orcid":"https://orcid.org/0000-0001-8364-0617","observed_orcids":["https://orcid.org/0000-0001-8364-0617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Driscoll","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8364-0617","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.06509999930858612,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.04179999977350235,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.9160000085830688},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/antigen-presentation","display_name":"antigen presentation","score":0.7950000166893005},{"id":"https://openalex.org/keywords/psma1","display_name":"PSMA1","score":0.871999979019165},{"id":"https://openalex.org/keywords/proteasome-activator","display_name":"proteasome activator","score":0.7269999980926514},{"id":"https://openalex.org/keywords/t-cell-immunotherapy","display_name":"T cell therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/tumor-surveillance","display_name":"tumor surveillance","score":0.7400000095367432},{"id":"https://openalex.org/keywords/allogeneic-t-cells","display_name":"allogeneic T cells","score":0.718999981880188},{"id":"https://openalex.org/keywords/personalized-cancer-vaccines","display_name":"personalized cancer vaccines","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.6487289071083069},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5953928232192993},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.5949203968048096},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.5819929838180542},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.540748119354248},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5090122222900391},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.5088965892791748},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.49414876103401184},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3863796889781952},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3510114252567291},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3193317651748657},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.31899625062942505},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2408277690410614},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22992166876792908},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06567946076393127}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.7567731","doi":"https://doi.org/10.1158/1535-7163.c.7567731","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.7567731","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.7567731","doi":"https://doi.org/10.1158/1535-7163.c.7567731","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.7567731","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402072240","https://openalex.org/W4393075364","https://openalex.org/W4405047818","https://openalex.org/W7130346631","https://openalex.org/W4389227693","https://openalex.org/W4386271027","https://openalex.org/W4417004740","https://openalex.org/W4389227766","https://openalex.org/W4404975781","https://openalex.org/W4396924324"],"abstract_inverted_index":{"Abstract":[0],"Proteasomes":[1],"generate":[2,41],"antigenic":[3,240],"peptides":[4,42,103,117],"that":[5,21,47,90,133],"are":[6,16,22],"presented":[7,104],"on":[8,105,124,175],"the":[9,34,50,63,70,97,112,138,147,170,194,216,230,239,243],"tumor":[10],"surface":[11],"to":[12,40,65,83,137,237],"cytotoxic":[13],"T-lymphocytes.":[14],"Immunoproteasomes":[15],"highly":[17],"specialized":[18],"proteasome":[19,37,139,148],"variants":[20],"expressed":[23],"at":[24],"higher":[25],"levels":[26],"in":[27,207,221],"antigen-presenting":[28],"cells":[29,189,214],"and":[30,74,95,99,120,143,184,199,209,248],"contain":[31],"replacements":[32],"of":[33,52,60,101,114,146,156,172,179,197,218,234],"three":[35],"constitutive":[36],"catalytic":[38],"subunits":[39],"with":[43,152,165,190,211],"a":[44,87],"hydrophobic":[45],"C-terminus":[46],"fit":[48],"within":[49],"groove":[51],"MHC":[53],"class":[54],"I":[55],"(MHC-I)":[56],"molecules.":[57],"A":[58,110,135,174,192,204],"hallmark":[59],"cancer":[61],"is":[62],"ability":[64],"evade":[66],"immunosurveillance":[67],"by":[68,118],"disrupting":[69],"antigen":[71,77,176],"presentation":[72,113],"machinery":[73],"downregulating":[75],"MHC-I":[76],"presentation.":[78,177],"High-throughput":[79],"screening":[80],"was":[81,205],"performed":[82],"identify":[84],"compound":[85,134,173,191],"A,":[86],"novel":[88],"molecule":[89],"selectively":[91],"increased":[92,111,193],"immunoproteasome":[93,235],"activity":[94,196],"expanded":[96],"number":[98],"diversity":[100],"MHC-I\u2013bound":[102,116],"multiple":[106,180],"myeloma":[107,125,181,219],"cells.":[108,126,202],"Compound":[109,203],"individual":[115],">100-fold":[119],"unmasked":[121],"tumor-specific":[122],"neoantigens":[123,251],"Global":[127],"proteomic":[128],"integral":[129],"stability":[130],"assays":[131],"determined":[132],"binds":[136],"structural":[140],"subunit":[141],"PSMA1":[142],"promotes":[144],"association":[145],"activator":[149],"PA28\u03b1/\u03b2":[150],"(PSME1/PSME2)":[151],"immunoproteasomes.":[153],"CRISPR/Cas9":[154],"silencing":[155],"PSMA1,":[157],"PSME1,":[158],"or":[159],"PSME2":[160],"as":[161,163],"well":[162],"treatment":[164],"immunoproteasome-specific":[166],"suicide":[167],"inhibitors":[168],"abolished":[169],"effects":[171],"Treatment":[178],"cell":[182],"lines":[183],"patient":[185],"bone":[186],"marrow\u2013derived":[187],"CD138+":[188],"anti-myeloma":[195],"allogenic":[198],"autologous":[200],"T":[201,213],"well-tolerated":[206],"vivo":[208],"co-treatment":[210],"allogeneic":[212],"reduced":[215],"growth":[217],"xenotransplants":[220],"NOD/SCID":[222],"gamma":[223],"mice.":[224],"Taken":[225],"together,":[226],"our":[227],"results":[228],"demonstrate":[229],"paradigm":[231],"shifting":[232],"impact":[233],"activators":[236],"diversify":[238],"landscape,":[241],"expand":[242],"immunopeptidome,":[244],"potentiate":[245],"T-cell\u2013directed":[246],"therapy,":[247],"reveal":[249],"actionable":[250],"for":[252],"personalized":[253],"T-cell":[254],"immunotherapy.":[255]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-12-04T00:00:00"}